Orthokine is a new treatment against osteoarthritis which is highly effective in knee arthritis as well as in degenerative backbone diseases and intervertebral disk diseases.
It is the first scientifically proven autologous product against placebos and corticosteroids.
Its main advantage as opposed to conventional therapies is that Orthokine is safe, tolerable (it has no side effects, unlike anti-inflammatory drugs) and its beneficial effects last longer: they have been proven to last for two years, and the patient’s quality of life in this period improves significantly. Therefore, fewer medical procedures are needed during this time, for the functionality and mobility of the joint is increased and pain is reduced. It is a safe long-term alternative to conventional treatments.
What does the treatment involve?
The treatment consists on the injection of proteins from the patient’s blood in the affected area. AUTOLOGOUS PROTEINS COMING FROM THE PATIENT AND FROM HIS/HER OWN BLOOD ARE USED and applied as a treatment.
Who administers the treatment?
Your traumatologist, neurosurgeon, rheumatologist or pain medicine specialist.
In which processes has it been scientifically proven?
Knee osteoarthritis: the therapy has been proven effective and safe. It significantly reduces pain and inflammation in every 3 out of 4 patients.
Back conditions: in degenerative back conditions, Orthokine is a clear alternative to current treatments. It improves degenerative processes of the back and intervertebral disks; it also diminishes pain significantly in every two out of three patients treated.
Which are the conventional therapies?
Steroids, hyaluronic acids and analgesics.